Advanced Search
Contact | Corporate | Help

Daily news email for May 14, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
Vetter Boosts Quality and Logistic Processes

Definiens Expands Functionality of Its Leading Solution for Quantitative Digital Pathology with ...

Antisense Pharma Internationalizes Management Board

Mucosis Announces Positive Proof-Of-Concept Data for Mimopath® Platform In Humans

Nuevolution Announces Receipt of Milestone Payment from Boehringer Ingelheim

 BioSpace
Almac Group Adds High-Speed Clinical Trial Blistering Equipment at US HQ

FDA Eases Sterility Test Requirement for Biologics

JumpStart to Create 40 More Top Quality Jobs for Scientific and Business Talent

Gene Therapy for Hearing Loss: Potential and Limitations, Emory University School of Medicine Study

Combo Therapy Reverses Diabetes in Mice, University of Florida Study

BioSpace - Breaking News
Biogen Idec, Inc. (Massachusetts)'s New AVONEX Dosing Innovations for People with Multiple Sclerosis Now Available in US

Cyclacel Pharmaceuticals, Inc. Announces Completion of Enrollment in Investigator-Initiated, Phase 2/3 Randomized Trial Comparing Sapacitabine to Low Dose Cytarabine

SLA Pharma AG Announces Clinically and Statistically Significant Phase 2 Results on Opioid Induced Constipation

Biovest International, Inc. to Seek Marketing Approval in the EU for BiovaxID Personalized Lymphoma Cancer Vaccine

Persistent Systems Release: New Biospecimens Management System in Development

Biotech News - Business Wire
BioAlliance Pharma SA: Initiation of ReLive, phase III clinical trial with Livatag® In primary liver cancer

The Orthopaedic Implant Company Launches Pedicle Screw System

Octagon Research Solutions, Inc. to Lead Seven Presentations at PharmaSUG Industry Conference

HemaCare Reports Improved Quarterly Results and Strengthened Balance Sheet

Critical Diagnostics Extends Its Asia Pacific Reach

 Biotech News - PR Newswire
Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis

Novocure Announces Launch of Recurrent Glioblastoma Product Website

Understanding the RNAi Reagents Market Overlap with Drug Discovery and Therapeutic Development is Critical for Pharmaceutical Leaders

Boston Scientific gibt ce-kennzeichnung und europäische markteinführung des selbstexpandierenden bare-metal-stentsystems Innova bekannt

Boston Scientific annuncia il ricevimento della marcatura ce e il lancio in europa dello stent autoespandibile Innova
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
Blech, One-Time "King of Biotech," Pleaded Guilty to Manipulating Stock Prices

Gilead's Truvada Gains Support for HIV Prevention

Daiichi Sankyo Enters Biosimilars Arena with Coherus BioSciences

Groups Weigh in on Biosimilars

Vertex's Cystic Fibrosis Considered Game-Changer

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Senesco to Present SNS01-T, an eIF5A-based Nanoparticle in a Phase 1b/2a Trial to Treat Multiple Myeloma, is Effective in Models of B-Cell Lymphoma

INC Research Selects TransPerfect's Trial Interactive Technology as its Electronic Trial Master File (eTMF) Solution

North Texas Accountable Healthcare Partnership Selects Orion Health for Regional Health Information Exchange

Highmark Inc. Selects Verisk Health's Analytics Engine to Drive Member Identification and Stratifcation as a Key Component of Its Clinical Transformation Project

Endosense Reports Strong Momentum for Contact-Force Sensing in Catheter Ablation at Heart Rhythm 2012

 Clinical Trials - PR Newswire
AG Mednet Launches New Technology to Expedite the Clinical Trial Decision-Making Process, Eliminating Costly Delays and Errors

Regentis Biomaterials Announces $10 Million Raised in Latest Round of Funding

Boston Scientific Announces CE Mark and European Launch of Innova Self-expanding Bare-metal Stent System

Preclinical data for Neovasc Inc.'s Tiara transcatheter mitral valve program to be presented at EuroPCR 2012

New Allon research presented at leading scientific symposium

 CNN Top Stories
Time running out for Greece

Missing FBI agent may be suicidal

FAMU band's suspension extended

Q&A: U.S. have options in Syria

Fate of FAMU's band on the line
Contract Pharma
OSI Wins $4.5 Million Contract

Quture Forms European Ops Subsidiary

INC Research Selects eTMF Solution

Maxygen Gains Final Bayer Payment

Vetter Completes Center for Visual Inspection and Logistics

 FDA Drugs- What's New
FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod)

FDA Drug Safety Communication: Safety review update of cancer drug Revlimid (lenalidomide) and risk of developing new types of malignancies

Comunicado de la FDA sobre la seguridad de los medicamentos: Información actualizada sobre la interacción entre el medicamento Victrelis (boceprevir) y ciertos medicamentos reforzados inhibidores de la proteasa del VIH

Comunicado de la FDA sobre la seguridad de los medicamentos: InformaciĂłn actualizada sobre la interacciĂłn entre el medicamento Victrelis (boceprevir) y ciertos medicamentos reforzados inhibidores de la proteasa del VIH

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva advertencia y contraindicación sobre medicamentos para la presión arterial que contienen aliskiren

 FDA News - Business Wire
El Comité Asesor de la FDA respalda la aprobación del régimen Quad de única pastilla una vez al día para el VIH de Gilead

Bioness Announces FDA Clearance of Smaller Leg Cuff for Use with Its L300 Foot Drop System

Fibrocell Science Submits a Phase II Study Protocol to the FDA to Evaluate the Use of azficel-T in Treating Restrictive Burn Scars

Late-Stage Drugs Are Hotbed for Co-Development and Licensing Deals

Hi-Tech Pharmacal to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
FDA Press Releases
FDA issues alert on potential dangers of unproven treatment for multiple sclerosis

FDA proposal aims to help reduce unnecessary radiation exposure for children

FDA issues final rule on sterility testing of biological products

FDA permits marketing of a new device for abdominal surgery

FDA approves new orphan drug to treat a form of Gaucher disease

 FDA Vaccines, Blood and Biologics - What's New
Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FDA Webinar on Safety of the Blood Supply

WinRho SDF Liquid

Flebogamma DIF 5%

 FierceBiotech
Serono workers plot strike, lash out over R&D failures

Lundbeck soars on PhIII success for blockbuster hopeful

Cancer drug developers angling for center stage at ASCO

OncoMed offers $115M IPO bet on cancer stem cell work

Big Pharma's high-risk pursuit of CNS gold faces major market doubts

FierceBiotech IT
Join a live Twitter chat with Medidata's Glen de Vries

Boehringer, pharmas turn to social gaming for online outreach

BioClinica chief touts Microsoft ties in Q1 report

NIH pumps $6M into DNA analysis for Alzheimer's plan

AstraZeneca leans on IT to transform an ailing business

 FierceBiotech Research
Preclinical breakthrough: Scientists beat rare skin cancer tumors

Researchers cure Type 1 diabetes in mice

Transplanted mouse fetal cells morph into viable rat kidneys

Researchers find key to premature aging syndrome

Honeybee substance freezes prostate cancer growth (Hint, it's not honey)

 FiercePharma
Clinical trials to size up antipsychotics like Seroquel for PTSD

Eisai broadens marketing deal for Arena's weight-loss drug

Sales-needy Takeda springs for emerging markets growth

Servier, founder face trial on Mediator charges

Shantha gets go-ahead for operational revamp
FiercePharma Manufacturing
Ranbaxy to make drugs in Malaysia, Nigeria

FDA critical of Genentech's Avastin production

12-year-old consent decree lifted from Abbott

Pfizer may announce $129M expansion in Belgium

Patheon exiting most manufacturing at U.K. plant

 FierceVaccines
UPDATED: Teen meningitis B vax successful in Phase II

MMR and autism: Italy's courts get involved

Pneumococcal vax cuts deaths, but cases tripled

First 'cross-kingdom' vax effective in PhI

Study: Further insight into Merck HIV vax infection increase

 Health News - BizJournals.com
John Malone invests $2M in Broomfield company

Delaware Hospice opening first Pa. site

Extendicare REIT exiting Kentucky market

Thomas Jefferson U. Hospital opens hepatitis C center

Wash U receives $8.3 million to treat malnutrition in children
Health News - CNBC
Marijuana may ease multiple sclerosis symptoms

Lundbeck says data supports H2 anti-depressant filing

French drugmaker on trial over weight-loss pill

More batteries to blame for kids' ER visits

Analysis: Health by numbers: A statistician's challenge

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
New UMass Accelerator to Focus on Growing Biomanufacturing

GSK, HGS Saddle Up for Acquisition Battle Valuing HGS at $2.6B

NCCN Foundation Announces 2012 Young Investigator Awards

GEN Poll Respondents 'somewhat Optimistic VC Market Will Improve This Year

Beckman Coulter to Start Sequencing Clinical Samples
Marketwire - Pharma and Biotech
Rosetta Genomics Announces One-for-Fifteen Reverse Stock Split

Imaging Diagnostic Signs Shimadzu Medical to Market Its CTLM(R) Laser Breast Imaging Device in Australia, New Zealand and the Pacific Islands

ProMetic Reports Its First Quarter 2012 Highlights and Financial Results

ProMetic annonce les faits saillants et rltats financiers du premier trimestre de 2012

International Drug & Explosives Detection Company IDenta Corp. Signs an Important Agreement in USA

 MassBio News
MassBio Honored with NORD's Power of Partnership Award

10 reasons to attend the BIO International Convention

New Therapy Helps Patients Soar to New Heights

BIO 2012 Massachusetts Pavillion Patient Profiles

By Popular Demand: New Professional Development Courses Aim to Meet Industry Needs

 Medical Pharma - PR Newswire
DICOM Grid Selected as a Finalist for the 2012 Red Herring Top 100 Americas Award

Does Gender Matter for Athlete Injuries

Accountable Healthcare Staffing announces opening of Clearwater, Florida branch office

Medical Students Without Borders

Nurse Practitioners Provide Solution To Shortage Of Primary Health Care Providers
National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

 Nature Biotechnology
High-efficiency TALEN-based gene editing produces disease-resistant rice

Recasting natural product research

A work in progress

Drug pipeline: 1Q12

Biotech equities heat up in 1Q12

 New York Times- Biotechnology
DEALBOOK; Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

White House Promotes a Bioeconomy

George Rathmann, Chief of Amgen, Dies at 84

Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research
New York Times- Pharmaceuticals
D.S.M. Revisions May Sharply Increase Addiction Diagnoses

Dialysis Rule Changes Followed by Transfusion Increases

F.D.A. Panel Backs Preventive Use of H.I.V. Drug Truvada

Diet Drug Wins Approval of F.D.A. Advisers

New Cautions About Long-Term Use of Bone Drugs

 OnBioVC
ImmuneXcite, Inc.: Series A $2.4M

AirXpanders, Inc.: Series D $10.3M

MC10, Inc.: Series B $2M

CN Creative, Ltd.: Series A $3.1M

SEA Medical Systems, Inc.: Series B $3M

 Outsourcing-Pharma
SGS adds formulation development services and expands US lab

Once a friend now an enemy: Over zealous EU regulators could hamper the CMO market, says analyst

Pharmas must give patients voice says DIA Europe director

Improve patient compliance by designing trials around real life, says expert

People special: social media gets job hunters noticed
Pharma News - Business Wire
Almac Adds High-Speed Clinical Trial Blistering Equipment at US HQ

Galderma Italy Deploys Comprehensive Cegedim Relationship Management Cloud-Based Solution Including Award-Winning* Mobile Intelligence for iPad and OneKey Database

Riassunto: Galderma Italia implementa la soluzione completa CRM cloud-based che comprende il pluripremiato* Mobile Intelligence for iPad e il database OneKey

Galderma Italia implementiert umfassende Cloud-basierte Lösung von Cegedim Relationship Management, darunter das preisgekrönte* Mobile Intelligence for iPad und die OneKey-Datenbank

BioAlliance Pharma SA: Démarrage de ReLive, essai clinique de phase III de Livatag® dans le cancer primitif du foie

 Pharma News - PharmiWeb
East Lancashire Hospitals NHS Trust orders Ascribe's ePrescribing and Business Change Consultancy

New Mexico Optometrists Partner With Rep. Powdrell-Culbert And Gov. Martinez To Improve Infant Eye And Vision Care

South Side Chicago Students Participate in Diabetes Awareness Screening and Treatment Program

John Rich & Friends Concert to Benefit St. Jude Children's Research Hospital®

Four Pennsylvania Nursing Homes Earn Awards for Excellence

 Pharma News - PR Newswire
Coping With New FDA Mandates For Drug Sample Distribution

myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development

Synchrogenix Opens in Sweden

Mylan lanceert Generiek Lipitor® in vijf Europese landen

The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

 PRWeb - Biotechnology
Moravia Worldwide Expands Linguistic Validation Services

WFT Cloud Announces SCIF Methodology at SAPPHIRE NOW + ASUG to Reduce...

Nebraska Doctor Claims to Highlight the Most Underreported Symptom of...

Cambridge Healthtech Associates Announces arGEN-X as Inaugural...

DuPont Tate & Lyle Bio Products Partners with Bio-Botanica®...
PRWeb - Pharmaceuticals
Bonita Dermatology, Now Offering The Latest Photodynamic Cosmetic...

Incidence of Coronary Heart Disease and Favorable Reimbursement...

ERA Clinical announces the Launch of its first Global Investigator...

Incidence of Metabolic Conditions, CNS, and Cardiovascular Diseases...

Aging Population, Growing Awareness and Novel Therapeutics Drives the...

 Scientific American
In Search of the Best (Energy) Ideas: A Q&A with ARPA-E's Arun Majumdar

In Search of the Best (Energy) Ideas: A Q&A with ARPA E's Arun Majumdar

Ancient Time: Earliest Mayan Astronomical Calendar Unearthed in Guatemala Ruins

Climate Forecasting: A Break in the Clouds

Hive and Seek: Domestic Honeybees Keep Disappearing, but Are Their Wild Cousins in Trouble, Too [Slide Show]

 Sports - ESPN Basketball
Bennett, No. 7 overall, picks UNLV over Oregon

HOF coach Nelson earns degree, 50 years later

Notre Dame's Martin granted 6th year by NCAA

Judge tosses defamation suit against Boeheim

Nebraska gives Miles 7 years, $1.4M annually
Sports News - ESPN
Florida A&M marching band to stay suspended

Former longtime Hurricanes AD Dee dies at 65

Arkansas WRs, TE arrested for dorm burglaries

Pitt sues Big East, hopes to move up exit date

Sandusky shower date change may nix charge

 Xconomy Life Sciences
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show

Boston Life Sciences News From Vertex, Eleven, RXi, & More

Verdezyne Raises $10.6M to Advance Sustainable Chemicals Technology

SD Life Sciences Roundup: Celladon, Vertex, MediciNova, & More

IDRI, Aeras Team Up to Develop Tuberculosis Vaccine

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012